Increases in discontinuous rib cartilage and fused carpal bone in rat fetuses exposed to the teratogens, busulfan, acetazolamide, vitamin A, and ketoconazole

Human and Experimental Toxicology

Volumn 29, Issue 6, 2010, Pages 439-450

  Dodo, T ^a,b   Uchida, K ^a   Hirose, T ^a   Fukuta, T ^a   Kojima, C ^a   Shiraishi, I ^a   Kato, E ^a   Horiba, T ^a   Mineshima, H ^a   Okuda, Y ^a   Maeda, M ^a   Katsutani, N ^a   Hirano, K ^b   Aoki, T ^a  

^a EISAI CO LTD   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Busulfan; Discontinuous rib cartilage; Fused carpal bone; Ketoconazole; Vitamin A palmitate

Indexed keywords

ACETAZOLAMIDE; BUSULFAN; KETOCONAZOLE; RETINOL PALMITATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARPAL BONE; CHONDROPATHY; CONTROLLED STUDY; FEMALE; FETUS; FOREFOOT; FORELIMB; GESTATION PERIOD; HAND BONE; MALE; NONHUMAN; PHALANX; PRIORITY JOURNAL; RAT; RIB MALFORMATION; SKELETON MALFORMATION; TERATOGENICITY;

ABNORMALITIES, DRUG-INDUCED; ACETAZOLAMIDE; ANIMALS; BUSULFAN; CARPAL BONES; CARTILAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETAL DEATH; FETAL DEVELOPMENT; FETAL RESORPTION; FETAL WEIGHT; FETUS; KETOCONAZOLE; PREGNANCY; RANDOM ALLOCATION; RATS; RIBS; TERATOGENS; VITAMIN A;

RATTUS;

EID: 77952244824     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327110363862     Document Type: Article

References (37)

1. Lenz, W. Thalidomide and congenital abnormalities. Lancet 1962 ; 1: 271-272.
2. ICH Harmonized Tripartite Guideline, Detection of Toxicity to Reproduction for Medicinal Products & Toxicity to Male Fertility S5 (R2). 1995.
3. OECD Guidelines for the Testing of Chemicals, Test No. 414: Prenatal Developmental Toxicity Study, 2001.
4. Rahman ME, Ishikawa H., Watanabe Y., Endo A. Carpal and tarsal bone development is highly sensitive to three antiproliferative teratogens in mice. Reprod Toxicol 1996 ; 10: 485-489.
5. Igarashi E. Malformations of cartilaginous and ossified axial skeleton in rat fetuses treated with cyclophosphamide: type, frequency, and stage specificity. Congenit Anom 1998 ; 38: 39-55.
6. Menegola E., Broccia ML, Di Renzo F., Giavini E. Comparative study of sodium valproate-induced skeletal malformations using single or double staining methods. Reprod Toxicol 2002 ; 16: 815-823.
7. Dodo T., Fukuta T., Uchida K., Katsutani N., Hirano K., Aoki T., et al. A comparative investigation of fetal skeletal malformations in rats induced by acetylsalicylic acid with single- and double-staining techniques. Regul Toxicol Pharm 2009 ; 54: 308-313.
8. Kimmel CA, Wilson JG, Schumacher HJ Studies on metabolism and identification of the causative agent in aspirin teratogenesis in rats. Teratology 1971 ; 4: 15-24.
9. Gupta U., Cook JC, Tassinari MS, Hurtt ME Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms. Birth Defects Res B 2003 ; 68: 27-37.
10. Layton WM Jr., Hallesy DW Deformity of forelimb in rats: association with high doses of acetazolamide. Science 1965 ; 149: 306-308.
11. Wilson JG, Maren TH, Takana K., Ellison A. Teratogenic action of carbonic anhydrase inhibitors in the rat. Teratology 1968 ; 1: 51-60.
12. Noda A., Sato M., Udaka K. Toxicity study of etretinate (IV) - teratological examination with single administration of etretinate in rats. Jpn Pharmacol Ther 1982 ; 10: 101-127.
13. Bishop JB, Wassom JS Toxicological review of busulfan (myleran). Mutat Res 1986 ; 168: 15-45.
14. Cauteren VH, Lampo A., Vandenberghe J., Marsboom R., et al. Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses 1989 ; 32: 60-66.
15. Amaral VCS, Nunes GP Jr. Ketoconazole- and fluconazole-induced embryotoxicity and skeletal anomalies in Wistar rats: a comparative study. Braz Arch Biol Technol 2008 ; 51: 1153-1161.
16. Inouye M. Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Congenit Anom 1976 ; 16: 171-173.
17. McLeod MJ Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology 1980 ; 22: 299-301.
18. Young AD, Phipps DE, Astroff AB Large-scale double-staining of rat fetal skeletons using alizarin red S and alcian blue. Teratology 2000 ; 61, 273-276.
19. Igarashi E., Kawamura N., Okumura H., Yasuda M., et al. Frequency of spontaneous axial skeletal variations detected by the double staining technique for the ossified and cartilaginous skeleton. Congenit Anom 1992 ; 32: 381-391.
20. Yasuda M., Yuki T. Color atlas of fetal skeleton of the mouse, rat, and rabbit. Japan Ace Art Co., Ltd., Osaka, Japan, 1996.
21. Menegola E., Broccia ML, Giavini E. Atlas of rat fetal skeleton double stained for bone and cartilage. Teratology 2001 ; 64: 125-133.
22. Le Borgne M., Marchand P., Le Baut G., Ahmadi M., Smith HJ, Nicholls PJ Retinoic acid metabolism inhibition by 3-azolylmethyl-1H-indols and 2, 3 or 5-(alpha-azolylbenzyl)-1H-indols. J Enzyme Inhib Med Chem 2003 ; 18: 155-158.
23. Menegola E., Broccia ML, Renzo FD, Giavini E. Postulated pathogenic pathway in triazole fungicide induced dysmorphogenic effects. Reprod Toxicol 2006 ; 22: 186-195.
24. Tellone CI, Baldwin JK, Sofia RD Teratogenic activity in the mouse after oral administration of acetazolamide. Drug Chem Toxicol 1980 ; 3: 83-98.
25. Yasuda M., Maeda H. Significance of the lumbar rib as an indicator in teratogenicity tests. J Jpn Teratol Soc 1972 ; 12: 253-254.
26. Rengasamy P., Padmanabhan RR Experimental studies on cervical and lumbar ribs in mouse embryos. Congenit Anom 2004 ; 44: 156-171.
27. Akiyama H., Chaboissier MC, Martin JF, Schedl A., Crombrugge B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes & Dev 2002 ; 16: 2813-2828.
28. Imamura T., Miura T. The carpal bones in congenital hand anomalies: a radiographic study in patients older than ten years. J Hand Surg 1988 ; 13A-3: 650-656.
29. Sugiyama A. The proportion of the carpal bones among congenital abnormalities of hand - an analysis with transverse deficiencies, longitudinal deficiencies and polydactyly. Tokyo Jikeikai Med J 2005 ; 120: 177-188.
30. Muenke M., Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 1995 ; 11: 308-313.
31. Deng C., Wynshaw-Boris A., Zhou F., Kuo A., Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996 ; 84: 911-921.
32. Moloney DM, Wall SA, Ashworth GJ, Muenke M., Wilkie AO, et al. Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet 1997 ; 349: 1059-1062. (Pubitemid 27158251)
33. Naski MC, Colvin JS, Douglas CJ, Ornitz DM Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development 1998 ; 125: 4977-4988.
34. Wilkie OA, Bochukova EG, Hansen RM, Seller A., Lester T. Clinical dividends from the molecular genetic diagnosis of craniosynostosis. Am J Med Genet A 2006 ; 140A: 2631-2639.
35. Bi W., Deng JM, Zhang Z., Behringer RR, Crombrugghe BD Sox9 is required for cartilage formation. Nat Genet 1999 ; 22: 85-89.
36. Xie WF, Zhang X., Sakano S., Lefebvre V., Sandell LJ Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9. J Bone Miner Res 1999 ; 14: 757-763.
37. Sekiya I., Tsuji K., Koopman P., Nifuji A., Noda M., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is upregulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000 ; 275: 10738-10744.